Chronic Viral Hepatitis and TNF-α blockade [8]

Rheumatology

Volumn 46, Issue 8, 2007, Pages 1381-

  Raftery, Graham ^a   Griffiths, B ^b   Kay, L ^a   Kane, D ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; CASE REPORT; CHRONIC HEPATITIS; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; VIRUS REACTIVATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VIRUS ACTIVATION;

EID: 34547839807     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem082     Document Type: Letter

References (4)

1. Roux CH, Brocq O, Breuil V et al. Safety of anti-TNF alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis. Rheumatology 2006;45:1294-7.
2. Raftery G, Griffiths B, Kay L et al. Hepatitis B Virus and tumour necrosis factor alpha blocking agents. Ann Rheum Dis 2004;6.4(Suppi 2):iI2-ii12eLetter in response 15th February 2005.
3. Calabrese LH, Zein NN, Vassilopoulos D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis 2006;65:983-9.
4. Di Marco V, Marzano A, Lampertico P et al. Clinical outcome of HBeAg negative chronic hepatitis B in relation to virological response to lamivudine. Hepatology 2004;40:883-91.